Simrat Gill

Simrat Gill

Auto-generated profile, based on publicly available information

Simrat Gill

Department of Cardiovascular Sciences, University of Birmingham , Medical School, Vincent Drive, Birmingham B15 2TT

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 January 2023 in European Heart Journal
Verified
Journal Article
Open access
PDF file
SGSimrat K Gill
Simrat K Gill
AKAndreas Karwath
Andreas Karwath
HUHae-Won Uh
Hae-Won Uh
VCVictor Roth Cardoso
Victor Roth Cardoso
ZGZhujie Gu
Zhujie Gu
JCJulius Center
Julius Center
Artificial intelligence (AI) is increasingly being utilized in healthcare. This article provides clinicians and researchers with a step-wise foundation for high-value AI that can be applied to a variety of different data modalities. The aim is to improve the transparency and application of AI methods, with the potential to benefit patients in routine cardiovascular care. Following a clear research hypothesis, an AI-based workflow begins with data selection and pre-processing prior to analysis, with the type of data (structured, semi-structured, or unstructured) determining what type of pre-processing steps and machine-learning algorithms are required. Algorithmic and data validation should be performed to ensure the robustness of the chosen methodology, followed by an objective evaluation of performance. Seven case studies are provided to highlight the wide variety of data modalities and clinical questions that can benefit from modern AI techniques, with a focus on applying them to cardiovascular disease management.Despite the growing use of AI, further education for healthcare workers, researchers, and the public are needed to aid understanding of how AI works and to close the existing gap in knowledge. In addition, issues regarding data access, sharing, and security must be addressed to ensure full engagement by patients and the public. The application of AI within healthcare provides an opportunity for clinicians to deliver a more personalized approach to medical care by accounting for confounders, interactions, and the rising prevalence of multi-morbidity.

11 March 2022 in Heart
Verified
Journal Article
Open access
PDF file
SGSimrat Gill
Simrat Gill
KBKarina V Bunting
Karina V Bunting
CSClaudio Sartini
Claudio Sartini
VCVictor Roth Cardoso
Victor Roth Cardoso
NGNarges Ghoreishi
Narges Ghoreishi
DKDipak Kotecha
Dipak Kotecha
Objectives Timely diagnosis of atrial fibrillation (AF) is essential to reduce complications from this increasingly common condition. We sought to assess the diagnostic accuracy of smartphone camera photoplethysmography (PPG) compared with conventional electrocardiogram (ECG) for AF detection. Methods This is a systematic review of MEDLINE, EMBASE and Cochrane (1980–December 2020), including any study or abstract, where smartphone PPG was compared with a reference ECG (1, 3 or 12-lead). Random effects meta-analysis was performed to pool sensitivity/specificity and identify publication bias, with study quality assessed using the QUADAS-2 (Quality Assessment of Diagnostic Accuracy Studies-2) risk of bias tool. Results 28 studies were included (10 full-text publications and 18 abstracts), providing 31 comparisons of smartphone PPG versus ECG for AF detection. 11 404 participants were included (2950 in AF), with most studies being small and based in secondary care. Sensitivity and specificity for AF detection were high, ranging from 81% to 100%, and from 85% to 100%, respectively. 20 comparisons from 17 studies were meta-analysed, including 6891 participants (2299 with AF); the pooled sensitivity was 94% (95% CI 92% to 95%) and specificity 97% (96%–98%), with substantial heterogeneity (p<0.01). Studies were of poor quality overall and none met all the QUADAS-2 criteria, with particular issues regarding selection bias and the potential for publication bias. Conclusion PPG provides a non-invasive, patient-led screening tool for AF. However, current evidence is limited to small, biased, low-quality studies with unrealistically high sensitivity and specificity. Further studies are needed, preferably independent from manufacturers, in order to advise clinicians on the true value of PPG technology for AF detection.

15 November 2021 in Cardiology
Verified
Journal Article
Open access
PDF file
RSRachel Studer
Rachel Studer
CSClaudio Sartini
Claudio Sartini
KSKiliana Suzart-Woischnik
Kiliana Suzart-Woischnik
RARumjhum Agrawal
Rumjhum Agrawal
HNHarshul Natani
Harshul Natani
DKDipak Kotecha
Dipak Kotecha
Background: Transparent and robust real-world evidence sources are increasingly important for global health, including cardiovascular (CV) diseases. We aimed to identify global real-world data (RWD) sources for heart failure (HF), acute coronary syndrome (ACS), and atrial fibrillation (AF). Methods: We conducted a systematic review of publications with RWD pertaining to HF, ACS, and AF (2010–2018), generating a list of unique data sources. Metadata were extracted based on the source type (e.g., electronic health records, genomics, and clinical data), study design, population size, clinical characteristics, follow-up duration, outcomes, and assessment of data availability for future studies and linkage. Results: Overall, 11,889 publications were retrieved for HF, 10,729 for ACS, and 6,262 for AF. From these, 322 (HF), 287 (ACS), and 220 (AF) data sources were selected for detailed review. The majority of data sources had near complete data on demographic variables (HF: 94%, ACS: 99%, and AF: 100%) and considerable data on comorbidities (HF: 77%, ACS: 93%, and AF: 97%). The least reported data categories were drug codes (HF, ACS, and AF: 10%) and caregiver involvement (HF: 6%, ACS: 1%, and AF: 1%). Only a minority of data sources provided information on access to data for other researchers (11%) or whether data could be linked to other data sources to maximize clinical impact (20%). The list and metadata for the RWD sources are publicly available at www.escardio.org/bigdata. Conclusions: This review has created a comprehensive resource of CV data sources, providing new avenues to improve future real-world research and to achieve better patient outcomes.

23 October 2025 in European Heart Journal - Digital Health
Verified
Journal Article
Open access
ACAsgher Champsi
Asgher Champsi
KSKarin T Slater
Karin T Slater
SGSimrat Gill
Simrat Gill
TDTomasz Dyszynski
Tomasz Dyszynski
MSMegan Schröder
Megan Schröder
DKDipak Kotecha
Dipak Kotecha
Aims: Coded healthcare data are now commonly used in clinical research. This study aimed to assess the transparency of reporting within heart failure studies and employ machine learning to facilitate larger-scale evaluation. Methods & Results: A systematic search of EMBASE and MEDLINE (2015–2020) identified 4279 heart failure studies with accessible Extensible Markup Language published in the top 25 journals by impact factor. Manual extraction in a random sample of 170 studies by independent human reviewers characterized 40 studies (23.5%) that used coded healthcare data, with 34 of these (85%) reporting doing so and only 19 (47.5%) providing clear descriptions of dataset construction and linkage. Another 420 studies underwent manual annotation to further train a Natural Language Processing (NLP) model designed for this study to automate and upscale review. The NLP model processed 3689 studies with a high level of internal accuracy (area under the receiver operating characteristic curve 0.97 and F1 score 0.96). Overall, the NLP approach identified 782 studies (21.2%) that reported coded healthcare data usage (95% CI 19.8–20.9%). No correlation was found between the reporting of coded healthcare data use and the publication year (r = −0.05; P = 0.21) or citation count (r = −0.13; P = 0.12). Conclusion: One-fifth of contemporary heart failure research articles are already reporting the use of coded healthcare data, with at-scale evaluation facilitated by a machine-learning model. The limited transparency on how coded healthcare data were used in studies highlights the need for quality standards such as the CODE-EHR framework for the use of healthcare data in research.